Medication info
Alitnnon Soft Capsule 30 mg (Alitretinoin)

Alitnnon Soft Capsule 30 mg (Alitretinoin)

Prescription medicationSoft capsuleOral
Ingredient · strength
Alitretinoin›30mg / 1 capsule
Manufacturer / importer
Genupharm Co., Ltd.
Appearance
A reddish-brown oval soft capsule containing yellowish oily content.
Packaging
30 capsules/box [(10 capsules/PTP*3)]
Approval status
Active

MFDS item code 202002948 · Approved 2020.04.23

Summary

Main use
Treatment of chronic severe hand eczema in adults that has not responded to potent topical corticosteroids
Who takes it
Adults
Adult dose
Take 10~30mg once daily with or immediately after a meal. It is preferable to take it at the same time each day. The initial dose is alitretinoin 30mg, reduced to 10mg according to adverse reactions. Patients with diabetes, obesity, cardiovascular risk factors, or dyslipidemia: Administer an initial dose of 10mg and, if necessary, increase to 30mg according to tolerability and effect. Periodic monitoring of blood lipid profiles and blood glucose may be necessary during treatment with this medicine. Discontinue treatment as soon as the hands are clear or almost clear, or the treatment goal has been achieved. If hand eczema remains severe after the initial 12 weeks of treatment, discontinue treatment. Also discontinue treatment if the treatment goal has not been achieved by week 24.

Ingredients

Manufacturer
Genupharm Co., Ltd.

Efficacy & effects

Treatment of chronic severe hand eczema in adults that has not responded to potent topical corticosteroids

  • Chronic severe hand eczema.
View approved original text

This medication is used for the treatment of chronic severe hand eczema in adults that does not respond to at least 4 weeks of potent topical steroid treatment.

How to take

Adult dose

Take 10~30mg once daily with or immediately after a meal. It is preferable to take it at the same time each day. The initial dose is alitretinoin 30mg, reduced to 10mg according to adverse reactions. Patients with diabetes, obesity, cardiovascular risk factors, or dyslipidemia: Administer an initial dose of 10mg and, if necessary, increase to 30mg according to tolerability and effect. Periodic monitoring of blood lipid profiles and blood glucose may be necessary during treatment with this medicine. Discontinue treatment as soon as the hands are clear or almost clear, or the treatment goal has been achieved. If hand eczema remains severe after the initial 12 weeks of treatment, discontinue treatment. Also discontinue treatment if the treatment goal has not been achieved by week 24.

Precautions

This medication poses a very high risk of causing severe congenital malformations if used during pregnancy; therefore, women who are pregnant or may become pregnant must not take it. Pregnancy tests should be conducted prior to initiation of treatment and periodically during treatment; effective contraception must be used, and it should continue for a period after discontinuing treatment. Severe side effects such as acute pancreatitis could occur if triglyceride levels are very high; therefore, regular blood tests should be performed to monitor lipid levels. It is safest when prescribed by a specialist experienced in systemic retinoid therapy, and it should be avoided in patients with liver dysfunction, kidney dysfunction, thyroid abnormalities, or hypervitaminosis A. Caution is required in those with a history of mental illness or symptoms of depression; if symptoms worsen, immediate consultation with a healthcare professional is necessary. Common side effects during the treatment may include headaches, dry skin, chapped lips, flushing, increased triglycerides and cholesterol; if symptoms are severe, dosage adjustment or discontinuation may be required. Excessive exposure to ultraviolet light should be avoided, and sunscreen may be used as necessary; vigorous exercise should be avoided. If dryness of the eyes or changes in vision occur, inform the physician immediately; wearing glasses is recommended as contact lenses may be difficult to wear. This medication should not be shared with others, and blood donation should be avoided during treatment and for a certain period afterward. The medication should be swallowed with water either with or immediately after meals, and it must be stored in a cool place out of the reach of children and away from direct sunlight.

Side effects

  • Headache
  • erythema
  • flushing
  • increased triglycerides
  • increased cholesterol
  • decreased thyroid-stimulating hormone
  • decreased free T4
  • anemia
  • increased iron-binding capacity
  • decreased monocytes
Show 62 more
  • increased platelets
  • anaphylactic reaction
  • hypersensitivity reaction
  • depression
  • mood changes
  • suicidal ideation
  • dizziness
  • benign intracranial hypertension
  • conjunctivitis
  • dry eyes
  • eye irritation
  • blurred vision
  • cataract
  • decreased night vision
  • tinnitus
  • hypertension
  • vasculitis
  • nosebleed
  • nausea
  • dry mouth
  • vomiting
  • indigestion
  • inflammatory bowel disease
  • increased aminotransferases
  • dry skin and lips
  • cheilitis
  • eczema
  • dermatitis
  • hair loss
  • pruritus
  • rash
  • skin peeling
  • dry eczema
  • nail disorders
  • photosensitivity reactions
  • hair texture abnormalities
  • arthralgia
  • myalgia
  • acromegaly
  • ankylosing spondylitis
  • fatigue
  • peripheral edema
  • hypertriglyceridemia
  • reduced HDL
  • hypercholesterolemia
  • increased serum creatine phosphokinase
  • diabetes
  • color blindness
  • intolerance to contact lenses
  • premature epiphyseal closure
  • hyperostosis
  • calcification of ligaments and tendons
  • corneal opacity
  • keratitis
  • inflammatory bowel disease
  • skin allergic reactions
  • anaphylactic reaction
  • purpura
  • severe allergic vasculitis
  • erythema multiforme
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and must be stored in a container that blocks light. Additionally, it is important to store it in a cool place at a temperature below 30 degrees Celsius to maintain its efficacy.

Appearance and packaging

Appearance

A reddish-brown oval soft capsule containing yellowish oily content.

Package unit

30 capsules/box [(10 capsules/PTP*3)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.